New five-year drugs pricing deal could lead to shortages, warns BGMA
A new five-year voluntary scheme for branded medicines pricing will double the cap on branded medicines sales growth to 4%, the government and industry have announced.
A new five-year voluntary scheme for branded medicines pricing will double the cap on branded medicines sales growth to 4%, the government and industry have announced.
